Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to res... Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population. Mehr anzeigen
Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU PR Newswire GAITHERSBURG, Md., Oct. 9, 2024 GAITHERSBURG, Md., Oct. 9, 2024 /PRNewswire/ -- Novavax, Inc...
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development PR Newswire GAITHERSBURG, Md., Sept. 25, 2024 Ruxandra Draghia-Akli, MD, PhD brings...
Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. PR Newswire GAITHERSBURG, Md., Sept. 13, 2024 Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now...
Novavax to Participate in Upcoming September Conferences PR Newswire GAITHERSBURG, Md., Sept. 4, 2024 GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global...
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. PR Newswire GAITHERSBURG, Md., Aug. 30, 2024 Novavax expects pre-filled syringes will be broadly...
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. PR Newswire GAITHERSBURG, Md., Aug. 30, 2024 Novavax expects pre-filled syringes will be broadly...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.37 | 3.00324675325 | 12.32 | 15.22 | 12.18 | 8020162 | 14.10157524 | CS |
| 4 | -0.01 | -0.0787401574803 | 12.7 | 15.22 | 11.09 | 6890676 | 13.14319862 | CS |
| 12 | -3.5 | -21.6182828907 | 16.19 | 17.81 | 8.87 | 6544418 | 13.13370428 | CS |
| 26 | 8.27 | 187.104072398 | 4.42 | 23.8599 | 3.81 | 11312740 | 13.16255309 | CS |
| 52 | 5.26 | 70.7940780619 | 7.43 | 23.8599 | 3.5324 | 9524668 | 9.97706587 | CS |
| 156 | -149.18 | -92.1603756101 | 161.87 | 236.5 | 3.5324 | 7504825 | 29.58504864 | CS |
| 260 | 7.94 | 167.157894737 | 4.75 | 331.5388 | 3.5324 | 6652847 | 54.92284713 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
